Sustainability & Climate

The high-tech wheel maker's stock plummets 65% as it fails to meet listing rules, signaling deep financial and operational distress for the company.

A small-cap food company plans a major NASDAQ leap, but its future hinges on a secret 'clean' technology. Can this ambitious, risky pivot succeed?

Ernexa Therapeutics secures crucial funding for its cancer therapy pipeline, but the dilutive offering sends its stock plunging more than 50%.

Strong investor demand boosts financing for BC's Golden Triangle exploration, highlighting Canada's strategic push into the critical minerals sector.

Upexi's new funding bolsters its ambitious Solana treasury, but the deal's terms, including warrant adjustments, raise dilution concerns for investors.

CR Fitness Holdings announces a 43,000 sq ft Crunch gym in Maitland, signaling a major move in Central Florida's competitive fitness market.

Australian biotech Immutep reaches a key milestone in its Phase III trial for a novel lung cancer therapy, a major step in a multi-billion dollar market.

As DICK'S Sporting Goods preps its Q4 report, all eyes are on the costly Foot Locker integration and whether its core business can offset the drag.

A European company with Big Pharma roots brings its natural allergy aid, SnizIQ, to California, tapping into a growing demand for alternatives.

For the 14th straight year, Herzing University earns top U.S. News rankings. Discover the model of support and career focus driving its sustained success.

The warehouse club operator signals robust confidence with a major dividend hike and plans for four new stores, pushing its stock to near-record highs.

As Dauch Corp, formerly American Axle, prepares its Q4 results, all eyes are on its powertrain-agnostic strategy and the integration of Dowlais Group.

Emirates Flight Catering's massive new biodigester system from Power Knot processes tonnes of daily food waste, setting a new sustainability standard.

Aucta Pharma launches two rare disease drugs, PYQUVI and ZELVYSIA, betting on a 'branded-generic' model to navigate highly competitive markets.

Kelun-Biotech's sac-TMT gains its fourth approval in China, doubling survival time for patients with advanced HR+/HER2- breast cancer.

Manipal's new comprehensive cancer centre in South Bengaluru integrates robotic surgery, precision radiation, and holistic support to combat rising cancer rates.

Go beyond the postcard. A new immersive tour in Tokyo lets you walk through ukiyo-e landscapes and print Hokusai's famous "Great Wave" yourself.

A new report predicts autonomous AI agents will soon run marketing, transforming brand-consumer relationships and the very role of the CMO. Are you ready?

Akeso's innovative dual-action antibody secures its fifth breakthrough nod, offering a lifeline for patients with advanced biliary tract cancer.

Ascentage Pharma's next-gen BTK degrader, APG-3288, receives dual IND clearance, paving the way for clinical trials to fight resistant blood cancers.